Corina Lesseur1, David A Armstrong1, Alison G Paquette1, Zhigang Li2, James F Padbury3, Carmen J Marsit4. 1. Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, NH. 2. Section of Biostatistics and Epidemiology, Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH. 3. Department of Pediatrics, Women and Infants Hospital of Rhode Island, Brown University, Providence, RI. 4. Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, NH; Section of Biostatistics and Epidemiology, Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH. Electronic address: Carmen.J.Marsit@dartmouth.edu.
Abstract
OBJECTIVE: In this study, we aimed to investigate relationships between maternal prepregnancy obesity and gestational diabetes mellitus and placental leptin DNA methylation. STUDY DESIGN: This study comprises data on 535 mother-infant dyads enrolled in the Rhode Island Child Health Study, a prospective cohort study of healthy term pregnancies. Prepregnancy body mass index was calculated from self-reported anthropometric measures and gestational diabetes mellitus diagnoses gathered from inpatient medical records. DNA methylation of the leptin promoter region was assessed in placental tissue collected at birth using quantitative bisulfite pyrosequencing. RESULTS: In a multivariable regression analysis adjusted for confounders, infants exposed to gestational diabetes mellitus had higher placental leptin methylation (β = 1.89, P = .04), as did those demonstrating prepregnancy obesity (β = 1.17, P = .06). Using a structural equations model, we observed that gestational diabetes mellitus is a mediator of the effects of prepregnancy obesity on placental leptin DNA methylation (β = 0.81, 95% confidence interval, 0.27-2.71). CONCLUSION: Our results suggest that the maternal metabolic status before and during pregnancy can alter placental DNA methylation profile at birth and potentially contribute to metabolic programming of obesity and related conditions.
OBJECTIVE: In this study, we aimed to investigate relationships between maternal prepregnancy obesity and gestational diabetes mellitus and placental leptin DNA methylation. STUDY DESIGN: This study comprises data on 535 mother-infant dyads enrolled in the Rhode Island Child Health Study, a prospective cohort study of healthy term pregnancies. Prepregnancy body mass index was calculated from self-reported anthropometric measures and gestational diabetes mellitus diagnoses gathered from inpatient medical records. DNA methylation of the leptin promoter region was assessed in placental tissue collected at birth using quantitative bisulfite pyrosequencing. RESULTS: In a multivariable regression analysis adjusted for confounders, infants exposed to gestational diabetes mellitus had higher placental leptin methylation (β = 1.89, P = .04), as did those demonstrating prepregnancy obesity (β = 1.17, P = .06). Using a structural equations model, we observed that gestational diabetes mellitus is a mediator of the effects of prepregnancy obesity on placental leptin DNA methylation (β = 0.81, 95% confidence interval, 0.27-2.71). CONCLUSION: Our results suggest that the maternal metabolic status before and during pregnancy can alter placental DNA methylation profile at birth and potentially contribute to metabolic programming of obesity and related conditions.
Authors: Kathleen M Rasmussen; Barbara Abrams; Lisa M Bodnar; Nancy F Butte; Patrick M Catalano; Anna Maria Siega-Riz Journal: Obstet Gynecol Date: 2010-11 Impact factor: 7.661
Authors: Elizabeth T Jensen; Jelske W van der Burg; Thomas M O'Shea; Robert M Joseph; Elizabeth N Allred; Tim Heeren; Alan Leviton; Karl C K Kuban Journal: J Pediatr Date: 2017-03-21 Impact factor: 4.406
Authors: C Allard; V Desgagné; J Patenaude; M Lacroix; L Guillemette; M C Battista; M Doyon; J Ménard; J L Ardilouze; P Perron; L Bouchard; M F Hivert Journal: Epigenetics Date: 2015 Impact factor: 4.528
Authors: Shali Mazaki-Tovi; Adi L Tarca; Edi Vaisbuch; Juan Pedro Kusanovic; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Zhong Dong; Sonia S Hassan; Roberto Romero Journal: J Perinat Med Date: 2016-10-01 Impact factor: 1.901
Authors: Matthew Bucher; Kim Ramil C Montaniel; Leslie Myatt; Susan Weintraub; Hagai Tavori; Alina Maloyan Journal: J Dev Orig Health Dis Date: 2020-11-13 Impact factor: 2.401
Authors: Teresa E Daniels; Alexander I Sadovnikoff; Kathryn K Ridout; Corina Lesseur; Carmen J Marsit; Audrey R Tyrka Journal: Mol Cell Endocrinol Date: 2020-01-29 Impact factor: 4.102